Evidence map›Paper›PMID 29255262›Full record

ArticleNature genetics2018

Mutations in SELENBP1, encoding a novel human methanethiol oxidase, cause extraoral halitosis.

Arjan Pol, G Herma Renkema, Albert Tangerman, Edwin G Winkel, Udo F Engelke, Arjan P M de Brouwer, Kent C Lloyd, Renee S Araiza, Lambert van den Heuvel, Heymut Omran and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 128 citations in OpenAlex.

  1. Article
  2. Article
  3. Correlation analysis of gut microbiota and metabolites in gastric cancer patients in plateau areas based on multi-omics technologies.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Black gas, bright future: HNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 5 countries.

Arjan Pol *Department of Microbiology, IWWR, Faculty of Science, Radboud University, Nijmegen, The Netherlands.
G Herma Renkema *Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre (RUNMC), Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0002-8174-6538
Albert TangermanDepartment of Internal Medicine, RUNMC, Nijmegen, The Netherlands.
Edwin G WinkelCenter for Dentistry and Oral Hygiene, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Udo F EngelkeTranslational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre (RUNMC), Nijmegen, The Netherlands.
Arjan P M de BrouwerDepartment of Human Genetics, RUNMC, Nijmegen, The Netherlands.
Kent C LloydDepartment of Surgery, School of Medicine, and Mouse Biology Program, University of California, Davis, Davis, CA, USA.ORCID http://orcid.org/0000-0002-5318-4144
Renee S AraizaMouse Biology Program, University of California, Davis, Davis, CA, USA.
Lambert van den HeuvelTranslational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre (RUNMC), Nijmegen, The Netherlands.
Heymut OmranKlinik für Kinder und Jugendmedizin, Universitätsklinikum Münster, Münster, Germany.
Heike OlbrichKlinik für Kinder und Jugendmedizin, Universitätsklinikum Münster, Münster, Germany.
Marijn Oude ElberinkTranslational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre (RUNMC), Nijmegen, The Netherlands.
Christian GilissenDepartment of Human Genetics, RUNMC, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0003-1693-9699
Richard J RodenburgTranslational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre (RUNMC), Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0001-5227-3527
Jörn Oliver SassBioanalytics and Biochemistry, Department of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, Rheinbach, Germany.
K Otfried SchwabDepartment of Pediatrics and Adolescent Medicine, University Hospital Freiburg, Freiburg, Germany.
Hendrik SchäferSchool of Life Sciences, University of Warwick, Coventry, UK.
Hanka VenselaarCentre for Molecular and Biomolecular Informatics, RUNMC, Nijmegen, The Netherlands.
J Silvia SequeiraMetabolic Unit-Pediatric Department, Hospital de Dona Estefânia, CHLC, Lisbon, Portugal.
Huub J M Op den CampDepartment of Microbiology, IWWR, Faculty of Science, Radboud University, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0003-1990-9030
Ron A WeversTranslational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre (RUNMC), Nijmegen, The Netherlands. ron.wevers@radboudumc.nl.ORCID http://orcid.org/0000-0003-2278-9746
Radboud University Nijmegen · NLKlinik und Poliklinik für Kinder- und Jugendmedizin · DEUniversity of California, Davis · USHochschule Bonn-Rhein-Sieg · DEHospital de Dona Estefânia · PTUniversity Medical Center Freiburg · DEUniversity Medical Center Groningen · NLUniversity of Warwick · GB

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
KOMP2-Phase3 Production and Phenotyping by the DTCC Consortium TCP Transfer to UC DavisUM1OD023221 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KC KENT LLOYD · 2016 to 2026
$45.7M
UCD Mutant Mouse Regional Resource CenterU42OD012210 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KC KENT LLOYD · 2012 to 2026
$29.2M
Biotechnology and Biological Sciences Research Council BB/H003851/1European Research Council 669371NCI NIH HHS P30 CA093373NIH HHS U42 OD012210NIH HHS UM1 OD023221
6 · The paper itself

Abstract

Selenium-binding protein 1 (SELENBP1) has been associated with several cancers, although its exact role is unknown. We show that SELENBP1 is a methanethiol oxidase (MTO), related to the MTO in methylotrophic bacteria, that converts methanethiol to H

Indexed as

AnimalsBreath TestsCell LineCells, CulturedDimethyl SulfoxideHalitosisHumansMice, Inbred C57BLMice, KnockoutMutationOxidoreductasesSelenium-Binding ProteinsDimethyl SulfoxideOxidoreductasesSELENBP1 protein, humanSelenbp1 protein, mouseSelenium-Binding Proteins

Identifiers

PMID29255262
PMCPMC5742538
OpenAlexW2771155712

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.